Skip to content

Clinical trials

Completed Phase 2 Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 2 Status: Completed Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20023
20032
20046
200511
20067
20078
20083
20092
20103
20115
20124
20131
20141
20157
20162
20171
20181
20192
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology12
National Cancer Institute (NCI)8
SWOG Cancer Research Network8
Novartis Pharmaceuticals5
Radiation Therapy Oncology Group5
Swiss Cancer Institute5
Wake Forest University Health Sciences3
Case Comprehensive Cancer Center2
Eastern Cooperative Oncology Group2
Memorial Sloan Kettering Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung88
Carcinoma, Non-Small-Cell Lung74
Lung Neoplasms65
Adenocarcinoma, Bronchiolo-Alveolar38
Brain Neoplasms2
Drug-Related Side Effects and Adverse Reactions2
Neoplasm Metastasis2
Neoplasms2
Pleural Effusion, Malignant2
Adenocarcinoma1

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.